Intelligent Bio Solutions INBS
NASDAQ INBS
$1.63 -0.02 (-1.21%)
As of: Sep 29, 2026 · 3:59 PM EDT

Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024)

Updated

Intelligent Bio Solutions' Non-Current Debt was $150,426 in fiscal Q3 2024 (quarter ended Mar 31, 2024), down 68.1% from $470,872 a year earlier and down 34.9% from the prior quarter.

Analysis

Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024) Analysis & Trends

At the end of FY2023 (ended Jun 30, 2023), Non-Current Debt at Intelligent Bio Solutions came in at $402,862.

  • Per Business Quant data, INBS's Non-Current Debt in the three fiscal quarters before Q3 2024 was $230,969 (Q2 2024), $306,234 (Q1 2024) and $402,862 (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 39.18 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 29.60 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 25.15 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.62 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 14.19 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 10.92 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 13.51 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 598.70 Mn
10 Intelligent Bio Solutions 2.43 Mn -11.04 Mn 536,583.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 150,426.00
Dec 31, 2023 230,969.00
Sep 30, 2023 306,234.00
Jun 30, 2023 402,862.00
Mar 31, 2023 470,872.00
Dec 31, 2022 507,403.00
API Access

Intelligent Bio Solutions Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INBS&period=max&api_key=YOUR_API_KEY